Govt Caps Trade Margins on 137 Anti-Cancer Drugs To Lower Treatment Costs

The Hindu · india

The National Pharmaceutical Pricing Authority has capped trade margins on 137 non-scheduled anti-cancer medicines at 30% of the price to the retailer, effective November 9. This move is expected to reduce prices by up to 70% for some drugs, potentially saving patients around ₹2,500 crore annually. While this offers some relief, oncologists note that high manufacturer prices and treatment costs beyond medicines remain significant challenges. Many patients struggle with the financial burden of prolonged cancer treatment, risking discontinuation of care.